Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
12:00 AM - Hepatology 2021
31
1
2
3
4
7
8
9
10
11
13
14
15
16
18
19
20
21
22
23
24
25
27
28
29
30
1
2
World Nanotechnology Congress 2021
2021-03-29    
All Day
Nano Technology Congress 2021 provides you with a unique opportunity to meet up with peers from both academic circle and industries level belonging to Recent [...]
Nanomedicine and Nanomaterials 2021
2021-03-29    
All Day
NanoMed 2021 conference provides the best platform of networking and connectivity with scientist, YRF (Young Research Forum) & delegates who are active in the field [...]
Smart Materials and Nanotechnology
2021-03-29 - 2021-03-30    
All Day
Smart Material 2021 clears a stage to globalize the examination by introducing an exchange amongst ventures and scholarly associations and information exchange from research to [...]
Hepatology 2021
2021-03-30 - 2021-03-31    
All Day
Hepatology 2021 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range [...]
Annual Congress on  Dental Medicine and Orthodontics
2021-04-05 - 2021-04-06    
All Day
Dentistry Medicine 2021 is a perfect opportunity intended for International well-being Dental and Oral experts too. The conference welcomes members from every driving university, clinical [...]
World Climate Congress & Expo 2021
2021-04-06 - 2021-04-07    
All Day
Climatology is the study of the atmosphere and weather patterns over time. This field of science focuses on recording and analyzing weather patterns throughout the [...]
European Food Chemistry and Drug Safety Congress
2021-04-12 - 2021-04-13    
All Day
We invite you to meet us at the Food Chemistry Congress 2021, where we will ensure that you’ll have a worthwhile experience with scholars of [...]
Proteomics, Genomics & Bioinformatics
2021-04-12 - 2021-04-13    
All Day
Proteomics 2021 is one of the front platforms for disseminating latest research results and techniques in Proteomics Research, Mass spectrometry, Bioinformatics, Computational Biology, Biochemistry and [...]
Plant Science & Physiology
2021-04-17 - 2021-04-18    
All Day
The PLANT PHYSIOLOGY 2021 theme has broad interests, which address many aspects of Plant Biology, Plant Science, Plant Physiology, Plant Biotechnology, and Plant Pathology. Research [...]
Pollution Control & Sustainable 2021
2021-04-26 - 2021-04-27    
All Day
Pollution Control 2021 conference is organizing with the theme of “Accelerating Innovations for Environmental Sustainability” Conference Series llc LTD organizes environmental conferences series 1000+ Global [...]
Events on 2021-03-30
Hepatology 2021
30 Mar 21
Events on 2021-04-06
Events on 2021-04-17
Events on 2021-04-26
Latest News

Medytox Solutions, Inc. Announces Release of M2Select EHR Product

medical mime

Medytox Solutions, Inc., which owns and operates a diverse family of healthcare companies, is pleased to announce that its wholly owned subsidiary Medical Mime, Inc. has entered into its first contracts for the deployment of its newly developed M2Select electronic health record product (EHR). Medical Mime, Inc. has designed M2Select as a customized EHR platform to service the needs of behavioral health rehabilitation and treatment facilities.

“We have made a significant investment in developing and testing M2Select,” said Seamus Lagan, CEO of Medytox Solutions, Inc. “Offering this new solution to medical providers expands our revenue and growth opportunities, and it is exciting to see that effort producing a completed product, which in turn is converting into sales.”

“Behavioral health rehabilitation and treatment facilities make up a significant part of our current customers, and the increased needs for technology and electronic communication solutions by all medical providers offers an opportunity for our IT and software subsidiaries,” Mr. Lagan added.

“M2Select offers a sophisticated, yet easy-to-use, EHR solution for our business. Ease of use combined with efficiency for our doctors and staff is a key element of providing better healthcare for our patients,” said Lawrence Hawkins, CEO of Q Health, a cutting-edge behavioral health company. “We have made a good choice by choosing Medytox as a service provider to our facilities.”

Medytox Solutions has enjoyed rapid growth through 2015 with the opening of their newest lab in Riviera Beach, Florida, and their pending merger with San Francisco-based CollabRx, which provides cancer treatment information based on the genetic analyses of patients’ cancer types. This proposed merger is intended to result in a full NASDAQ listing for the company. Medytox continues to explore opportunities to expand its diversified business focused on diagnostic laboratories, EHR software, physician billing, and healthcare finance.

For more information about Medytox Solutions, Inc., Medical Mime, and M2Select, please call Meieli Sawyer at 305-668-0070 or msawyer@weinbachgroup.com.

About Medytox Solutions, Inc.
Medytox Solutions Inc. (OTCQB: MMMS) Medytox Solutions, Inc. represents a new generation in healthcare — where integration leads to higher quality, better outcomes, and greater profitability. Today, Medytox applies its innovative approach to a growing family of companies that includes health IT and analytics, electronic health records software, medical billing, health-sector financing, and a large network of clinical laboratories serving healthcare and mental health providers.

About Medical Mime
Founded in 2010 by David Cooper and William Verhoeven, Medical Mime develops and markets cloud-based, electronic medical records (EHR), that use dictation-based note taking rather than template-based systems that rely on keyboard or touchscreen data entry. The company’s easy-to-use software has been adopted by physicians in a range of medical specialties, including primary care, and a recent version was launched to serve therapists working in drug and alcohol treatment facilities. Medical Mime’s software certified for Meaningful Use Phase I and pending certification for Meaningful Use Phase II.

Source